CITED2 anticorps (Internal Region)

N° du produit ABIN185552

Détail du produit anti-CITED2 anticorps

Antigène: CITED2 (Cbp/p300-Interacting Transactivator, with Glu/Asp-Rich Carboxy-terminal Domain, 2 (CITED2))

Épitope: Internal Region

Reactivité: Humain, Souris, Rat, Boeuf (Vache), Porc, Chien

Hôte: Chèvre

Clonalité: Polyclonal

Conjugué: Cet anticorp CITED2 est non-conjugé

Application: ELISA

Fonction: CITED2 (Internal)

Séquence: PNVIDTDFID EE

Homologie: Human, Mouse, Rat, Dog, Pig, Cow

Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Classe de qualité: Recent

Immunogène: Peptide with sequence C-PNVIDTDFIDEE, from the internal region of the protein sequence according to NP_006070.2.

Isotype: IgG

Information d'application

Indications d'application:

DS WB Results: Preliminary experiments in adult human heart, kidney, liver and skin lysates gave no specific signal but low background (at antibody concentration up to 1 μg/mL).

Peptide ELISA: antibody detection limit dilution 1:4000.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Minimize freezing and thawing.

Stock: -20 °C

Stockage commentaire: Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.

Détails sur CITED2

Antigène: CITED2 (Cbp/p300-Interacting Transactivator, with Glu/Asp-Rich Carboxy-terminal Domain, 2 (CITED2))

Autre désignation: CITED2 (CITED2 Produits)

Synonymes: anticorps mrg1, anticorps p35srj, anticorps zgc:103418, anticorps CITED2, anticorps cite2, anticorps ASD8, anticorps MRG-1, anticorps MRG1, anticorps P35SRJ, anticorps VSD2, anticorps AI835299, anticorps ER154-like, anticorps Mrg1, anticorps Msg2, anticorps Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 2, anticorps Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2, anticorps Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2, anticorps Cbp/p300-interacting transactivator 2, anticorps Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 2 L homeolog, anticorps cited2, anticorps CITED2, anticorps cite2, anticorps Cited2, anticorps cited2.L

Sujet: CITED2, Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 , HGNC:1987, MRG1, P35SRJ

ID gène: 10370

NCBI Accession: NP_006070

Pathways: Tube Formation